Ameriprise’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.91M | Sell |
498,395
-126,908
| -20% | -$2.52M | ﹤0.01% | 1827 |
|
|
2025
Q1 | $10.6M | Buy |
625,303
+123,494
| +25% | +$2.09M | ﹤0.01% | 1723 |
|
|
2024
Q4 | $9.27M | Buy |
501,809
+145,518
| +41% | +$2.69M | ﹤0.01% | 1859 |
|
|
2024
Q3 | $7.74M | Buy |
356,291
+1,566
| +0.4% | +$34K | ﹤0.01% | 2024 |
|
|
2024
Q2 | $6.96M | Sell |
354,725
-5,410
| -2% | -$106K | ﹤0.01% | 2041 |
|
|
2024
Q1 | $7.81M | Buy |
360,135
+109,514
| +44% | +$2.38M | ﹤0.01% | 2011 |
|
|
2023
Q4 | $7.25M | Buy |
250,621
+184,263
| +278% | +$5.33M | ﹤0.01% | 2057 |
|
|
2023
Q3 | $1.77M | Sell |
66,358
-6,017
| -8% | -$161K | ﹤0.01% | 2874 |
|
|
2023
Q2 | $2.68M | Sell |
72,375
-4,420
| -6% | -$164K | ﹤0.01% | 2733 |
|
|
2023
Q1 | $2.4M | Sell |
76,795
-1,861
| -2% | -$58.1K | ﹤0.01% | 2753 |
|
|
2022
Q4 | $2.34M | Sell |
78,656
-7,845
| -9% | -$234K | ﹤0.01% | 2738 |
|
|
2022
Q3 | $3.3M | Sell |
86,501
-11,755
| -12% | -$448K | ﹤0.01% | 2518 |
|
|
2022
Q2 | $5.36M | Sell |
98,256
-336
| -0.3% | -$18.3K | ﹤0.01% | 2222 |
|
|
2022
Q1 | $6.15M | Sell |
98,592
-10,511
| -10% | -$656K | ﹤0.01% | 2280 |
|
|
2021
Q4 | $11M | Sell |
109,103
-24,390
| -18% | -$2.45M | ﹤0.01% | 1914 |
|
|
2021
Q3 | $12M | Buy |
133,493
+35,181
| +36% | +$3.16M | ﹤0.01% | 1704 |
|
|
2021
Q2 | $9.02M | Buy |
98,312
+2,550
| +3% | +$234K | ﹤0.01% | 2018 |
|
|
2021
Q1 | $9.25M | Buy |
95,762
+32,296
| +51% | +$3.12M | ﹤0.01% | 1941 |
|
|
2020
Q4 | $3.31M | Buy |
63,466
+10,701
| +20% | +$558K | ﹤0.01% | 2533 |
|
|
2020
Q3 | $2.11M | Sell |
52,765
-45,170
| -46% | -$1.81M | ﹤0.01% | 2631 |
|
|
2020
Q2 | $1.57M | Sell |
97,935
-29,490
| -23% | -$472K | ﹤0.01% | 2721 |
|
|
2020
Q1 | $1.37M | Buy |
+127,425
| New | +$1.37M | ﹤0.01% | 2673 |
|